CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

E. Mejstríková, O. Hrusak, Michael J Borowitz, J. A. Whitlock, B. Brethon, T. M. Trippett, G. Zugmaier, L. Gore, A. Von Stackelberg, F. Locatelli

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article number1038
JournalBlood Cancer Journal
Volume7
Issue number12
DOIs
StatePublished - Dec 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Mejstríková, E., Hrusak, O., Borowitz, M. J., Whitlock, J. A., Brethon, B., Trippett, T. M., Zugmaier, G., Gore, L., Von Stackelberg, A., & Locatelli, F. (2017). CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment. Blood Cancer Journal, 7(12), [1038]. https://doi.org/10.1038/s41408-017-0023-x